Skip to main content
Clinical Trials/NCT03265782
NCT03265782
Unknown
Phase 4

Comparison Between the Effect of Oral Paracetamol Versus Oral Ibuprofen in the Treatment of Patent Ductus Arteriosus in Preterm and Low Birth Weight Infants

Ain Shams University0 sites30 target enrollmentJune 2015

Overview

Phase
Phase 4
Intervention
ibuprofen
Conditions
Patent Ductus Arteriosus
Sponsor
Ain Shams University
Enrollment
30
Primary Endpoint
closure of PDA
Last Updated
8 years ago

Overview

Brief Summary

Comparison between the safety and efficacy of oral paracetamol and oral ibuprofen in treatment of Patent Ductus Arteriosus (PDA) in premature infants

Detailed Description

A pilot study through which we have studied efficacy and safety of oral paracetamol and oral ibuprofen in treatment of hemodyamically significant pda in preterm neonates. 30 preterm neonates were included in the study 15 per each group. echo was done in the beginning and during treatment with both drugs to follow up the closure of the duct. Ibuprofen was given as 10 mg/kg/dose in the 1st day followed by 5 mg/kg/dose in the 2nd and 3rd days with follow up echo was done after finishing the course paracetamol was given as 15 mglkg/6 hrs for three days with follow up echo to check the ductal closure.

Registry
clinicaltrials.gov
Start Date
June 2015
End Date
January 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rania Ali El-Farrash

pricipal investigator

Ain Shams University

Eligibility Criteria

Inclusion Criteria

  • Gestational age ≤ 35 weeks
  • Aged 2-7 days with color Doppler echocardiographic evidence of PDA
  • Urine output more than 1 ml/kg/hr
  • Creatinine concentration level less than 1.8 mg/dl

Exclusion Criteria

  • Neonates who have one or more of the following criteria were excluded from the study:
  • Congenital heart diseases of any type including
  • Pulmonary stenosis
  • Anomalus in pulmonary venous drainage
  • Ventricular septal defect
  • Major congenital anomalies as hydrops fetalis
  • Low platelets count (less than 60, 000/mm3)

Arms & Interventions

ibuprofen group

treatment of pda with oral ibuprofen with a loading dose 10 mg/kg/ds in the first day followed by 5 mg/kg/ds in the second ant third days then a follow up echo is done

Intervention: ibuprofen

paracetamol group

treatment of pda with oral paracetamol with dose of 15 mg/kg/ds every 6 hours for 3 days then a follow up echo is done

Intervention: paracetamol

Outcomes

Primary Outcomes

closure of PDA

Time Frame: 6 days

Echo confirmed closure

Similar Trials